pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
CT-868
Type 1 Diabetes (Juvenile Diabetes)
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 1
CT-95
Bile Duct Cancer (Cholangiocarcinoma)
$CNTX
Context Therapeutics Inc.
0
catalysts
Preclinical
CTB-1
Osteosarcoma
GTS Biotech LLC
0
catalysts
Preclinical
CTH-401
Ovarian Cancer
← prev
page 79 of 271
next →
131
Pain
89
Neurology
1
Cartherics Pty Ltd
0
catalysts
Phase 1
CTIM-76
Endometrial Cancer
$CNTX
Context Therapeutics Inc.
0
catalysts
Phase 2
CTO-1681
Cytokine Release Syndrome (Cytokine Storm)
CytoAgents Inc
0
catalysts
Preclinical
CTP-45
Autoimmune Disorders
Celltrion Inc
0
catalysts
Preclinical
CTP-68
Autoimmune Disorders
Celltrion Inc
0
catalysts
Preclinical
CTR-107
Noregen
Diabetic Retinopathy
Caeregen Therapeutics LLC
0
catalysts
Phase 1
CTS-2016
Myelodysplastic Syndrome (Preleukemia)
CytosinLab Therapeutics Co Ltd
0
catalysts
Phase 1
CTT-1403
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Cancer Targeted Technology LLC
0
catalysts
Preclinical
CTX-002
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Ceria Therapeutics Inc
0
catalysts
Phase 1
CTX-10726
Endometrial Cancer
$COMP
Compass, Inc.
0
catalysts
Preclinical
CTX-187
Gram-Negative Bacterial Infections
Centauri Therapeutics Ltd
0
catalysts
Phase 1
CTX-8371
Head And Neck Squamous Cell Carcinoma (HNSC)
$COMP
Compass, Inc.
0
catalysts
Phase 2
CTx-001
Geographic Atrophy
B-cell lymphoma/leukemia 11A
Complement Therapeutics Ltd
0
catalysts
Phase 2
CTxPDE-6b
Retinitis Pigmentosa (Retinitis)
Coave Therapeutics
0
catalysts
Phase 2
CUE-101
Human Papillomavirus (HPV) Associated Cancer
$CUE
Cue Biopharma, Inc.
0
catalysts
Phase 1
CUE-102
Gastric Cancer
$CUE
Cue Biopharma, Inc.
0
catalysts
Preclinical
CUE-401
Gastritis
$CUE
Cue Biopharma, Inc.
0
catalysts
Preclinical
CUG repeat-targeted rSM
Myotonic Dystrophy
Arrakis Therapeutics Inc
0
catalysts
CURIST ACID RELIEF
CURIST ACID RELIEF (FAMOTIDINE 20 MG)
VKT PHARMA
0
catalysts
Phase 1
CUSP-06
Ovarian Cancer
OnCusp Therapeutics Inc
0
catalysts
Preclinical
CVX-20733
Coronavirus Disease 2019 (COVID-19)
Covirix Medical Pty Ltd
0
catalysts
Preclinical
CVX-20799
Coronavirus Disease 2019 (COVID-19)
Covirix Medical Pty Ltd
0
catalysts
Phase 2
CX-001
Nevus
Calissa Therapeutics
0
catalysts
Preclinical
CX-01
Gastrointestinal Radiation Toxicity
Ceramedix Holding LLC
0
catalysts
Preclinical
CX-011
Osteoarthritis
CarthroniX Inc
0
catalysts
Phase 2
CX-1739
Central Sleep Apnea
Glutamate receptor ionotropic AMPA
EndeavourRx LLC
0
catalysts
Phase 1
CX-213
Subarachnoid Hemorrhage
Cenyx Biotech Inc
0
catalysts
